![Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - 2021 - eJHaem - Wiley Online Library Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - 2021 - eJHaem - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3d1bbe11-d1cc-4358-b94b-30ace2280788/jha2.v2.3.cover.jpg?trick=1692411486942)
Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity - Papadopoulou - 2021 - eJHaem - Wiley Online Library
![IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING RUXOLITINIB.... EHA Library. Gavriilaki E. Jun 9 2021; 324976 IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING RUXOLITINIB.... EHA Library. Gavriilaki E. Jun 9 2021; 324976](https://library.ehaweb.org/image/abstracts/eha_2021/EHA-1827.png)
IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING RUXOLITINIB.... EHA Library. Gavriilaki E. Jun 9 2021; 324976
![Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients | Bone Marrow Transplantation Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-022-01675-w/MediaObjects/41409_2022_1675_Fig1_HTML.png)
Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients | Bone Marrow Transplantation
![Achilles ANAGNOSTOPOULOS | Chief Scientific Director | Doctor of Medicine | Research profile - Page 2 Achilles ANAGNOSTOPOULOS | Chief Scientific Director | Doctor of Medicine | Research profile - Page 2](https://i1.rgstatic.net/ii/profile.image/564121378144256-1511508425332_Q512/Achilles-Anagnostopoulos.jpg)
Achilles ANAGNOSTOPOULOS | Chief Scientific Director | Doctor of Medicine | Research profile - Page 2
![PDF) PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS PDF) PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS](https://i1.rgstatic.net/publication/373001791_PB1894_NPM1_MUTATED_ACUTE_MYELOID_LEUKEMIA_THE_CO-MUTATION_PATTERNS_MAY_BE_ASSOCIATED_WITH_PROGNOSIS/links/64d38b8fd3e680065aa2ae24/largepreview.png)
PDF) PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS
![ioannis Batsis email address & phone number | General Hospital of Thessaloniki "George PAPANIKOLAOU" MD contact information - RocketReach ioannis Batsis email address & phone number | General Hospital of Thessaloniki "George PAPANIKOLAOU" MD contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/irene-papanikolaou-c64f2c0a.jpg)